
Layla D. Berry
Examiner (ID: 16889, Phone: (571)272-9572 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1609, 1623, 1693 |
| Total Applications | 1713 |
| Issued Applications | 1092 |
| Pending Applications | 106 |
| Abandoned Applications | 561 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12908851
[patent_doc_number] => 20180194792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 15/915490
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915490
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915490 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | Mar 7, 2018 | Abandoned |
Array
(
[id] => 15355643
[patent_doc_number] => 10526422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Process for preparation and purification of Sugammades sodium
[patent_app_type] => utility
[patent_app_number] => 15/909824
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 7933
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15909824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/909824 | Process for preparation and purification of Sugammades sodium | Feb 28, 2018 | Issued |
Array
(
[id] => 18451468
[patent_doc_number] => 20230192746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => PROCESS FOR CRYSTALLIZING 2'-FUCOSYLLACTOSE AND RELATED COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/486227
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486227
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486227 | PROCESS FOR CRYSTALLIZING 2'-FUCOSYLLACTOSE AND RELATED COMPOSITIONS | Feb 28, 2018 | Abandoned |
Array
(
[id] => 15360853
[patent_doc_number] => 20200016191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => COMPOSITION FOR SKIN INJECTION
[patent_app_type] => utility
[patent_app_number] => 16/488939
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488939
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488939 | Composition for dermal injection | Feb 26, 2018 | Issued |
Array
(
[id] => 13898897
[patent_doc_number] => 20190038653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/904882
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15904882
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/904882 | COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES | Feb 25, 2018 | Abandoned |
Array
(
[id] => 12857860
[patent_doc_number] => 20180177794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT
[patent_app_type] => utility
[patent_app_number] => 15/902643
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15902643
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/902643 | METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT | Feb 21, 2018 | Abandoned |
Array
(
[id] => 13457757
[patent_doc_number] => 20180280421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/900570
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 382
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15900570
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/900570 | Uridine diphosphate derivatives, prodrugs, compositions and uses thereof | Feb 19, 2018 | Issued |
Array
(
[id] => 13840493
[patent_doc_number] => 20190023731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/899844
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15899844
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/899844 | CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS | Feb 19, 2018 | Abandoned |
Array
(
[id] => 16175471
[patent_doc_number] => 20200222439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => BILE ACID SYNTHESIS PROMOTER, COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS AND FOOD COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 16/493906
[patent_app_country] => US
[patent_app_date] => 2018-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493906 | BILE ACID SYNTHESIS PROMOTER, COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS AND FOOD COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS | Feb 18, 2018 | Abandoned |
Array
(
[id] => 18664258
[patent_doc_number] => 11771120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Functional crystalline sweetener
[patent_app_type] => utility
[patent_app_number] => 16/620947
[patent_app_country] => US
[patent_app_date] => 2018-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 5807
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620947 | Functional crystalline sweetener | Feb 11, 2018 | Issued |
Array
(
[id] => 15831829
[patent_doc_number] => 20200131196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => Rapamycin Analog
[patent_app_type] => utility
[patent_app_number] => 16/484665
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484665
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484665 | Rapamycin Analog | Feb 8, 2018 | Abandoned |
Array
(
[id] => 16060957
[patent_doc_number] => 10689410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Recovery of steviol glycosides
[patent_app_type] => utility
[patent_app_number] => 15/891898
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17542
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891898
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891898 | Recovery of steviol glycosides | Feb 7, 2018 | Issued |
Array
(
[id] => 15267283
[patent_doc_number] => 20190382375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => TRIAZOLE ANTIMICROBIAL DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/486761
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 694
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486761
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486761 | Triazole antimicrobial derivative, pharmaceutical composition and use thereof | Feb 7, 2018 | Issued |
Array
(
[id] => 15681359
[patent_doc_number] => 20200095343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => IMPROVED METHOD FOR THE PREPARATION OF SULFOBUTYLETHER BETA CYCLODEXTRIN SODIUM
[patent_app_type] => utility
[patent_app_number] => 16/484023
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484023 | Method for the preparation of sulfobutylether beta cyclodextrin sodium | Feb 6, 2018 | Issued |
Array
(
[id] => 15963065
[patent_doc_number] => 20200165284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => METHOD FOR PREPARING CANAGLIFLOZIN AMORPHOUS FORM
[patent_app_type] => utility
[patent_app_number] => 16/486985
[patent_app_country] => US
[patent_app_date] => 2018-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486985 | Method for preparing canagliflozin amorphous form | Feb 5, 2018 | Issued |
Array
(
[id] => 12813172
[patent_doc_number] => 20180162894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => PROCESSES FOR THE PREPARATION OF GALNAC ACID DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/890181
[patent_app_country] => US
[patent_app_date] => 2018-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15890181
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/890181 | Processes for the preparation of GalNAc acid derivatives | Feb 5, 2018 | Issued |
Array
(
[id] => 16437070
[patent_doc_number] => 20200354396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHOD FOR PREPARING TULATHROMYCIN
[patent_app_type] => utility
[patent_app_number] => 16/764396
[patent_app_country] => US
[patent_app_date] => 2018-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764396
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764396 | Method for preparing tulathromycin | Feb 4, 2018 | Issued |
Array
(
[id] => 14715523
[patent_doc_number] => 20190248825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => METHOD FOR PRODUCING FLAVONOID INCLUSION COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/097120
[patent_app_country] => US
[patent_app_date] => 2018-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097120 | Method for producing flavonoid inclusion compound | Jan 30, 2018 | Issued |
Array
(
[id] => 12746587
[patent_doc_number] => 20180140696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => ADJUVANT AND VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/875860
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875860
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/875860 | ADJUVANT AND VACCINE COMPOSITIONS | Jan 18, 2018 | Abandoned |
Array
(
[id] => 14662575
[patent_doc_number] => 10369164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/874604
[patent_app_country] => US
[patent_app_date] => 2018-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16755
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15874604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/874604 | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof | Jan 17, 2018 | Issued |